Cost effectiveness and cost utility analysis of Sacral Neuromodulation, Optimized Medical Treatment and Botulinum Neurotoxin in the treatment of idiopathic Overactive Bladder in Spain

Castro-Díaz D1, Arlandis-Guzman S2, Errando C3, Fernández-Fernández E4, Jiménez-Cidre M4, González-García P5, Crespo-Palomo C6, Stauble F7, Rodríguez-Barrios J M5, Brosa-Riestra M6

Abstract Category

Epidemiology & Outcomes Research

Abstract 343
Non-Discussion Posters
Scientific Non Discussion Poster Session 32
1. Hospital Universitario de Canarias. Santa Cruz de Tenerife, 2. Hospital Universitario La Fe. Valencia, 3. Fundació Puigvert. Barcelona, 4. Hospital Ramón y Cajal. Madrid, 5. Medtronic Ibérica, Madrid, 6. Oblikue Consulting, Barcelona, 7. Medtronic International Trading Sarl, Switzerland
Links

Abstract

27/04/2024 18:05:26